Aberdeen University has opened a new £1.6 million centre for Marine Biodiscovery, to specialise in drug discovery based on compounds found in marine organisms.
This is one of only three such centres in Europe and one of very few academic units in the world to bring together chemists and biologists with a brief to develop new pharmaceuticals.
The centre has a compound library sourced from marine organisms worldwide, which is available for use in research and drug discovery by the academic community and industry.
Ian Diamond, Principal and Vice-Chancellor, said the centre positions Aberdeen at the international forefront of drug discovery based on compounds from the sea. “One of the first interdisciplinary centres of its kind in the world, it draws together the university’s research strengths in chemistry and biological and medical sciences.”
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
